Home > Boards > US Listed > Medical - Equipment > Cytosorbents Corporation (CTSO)

you are allowed to post 1 more per

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
biotech48 Member Profile
 
Followed By 1
Posts 567
Boards Moderated 0
Alias Born 03/22/12
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/26/2021 6:11:44 PM
CytoSorbents to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum and Jefferies London Healthcare Conference PR Newswire (US) - 11/15/2021 4:30:00 PM
Cytosorbents EPS misses by $0.03, beats on revenue Seeking Alpha - 11/4/2021 4:29:11 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/4/2021 4:15:41 PM
CytoSorbents Reports Full Third Quarter 2021 Financial and Operational Results PR Newswire (US) - 11/4/2021 4:15:00 PM
Cytosorbents Q3 2021 Earnings Preview Seeking Alpha - 11/3/2021 5:35:41 PM
CytoSorbents Comments on REMOVE Study Presentation PR Newswire (US) - 10/20/2021 7:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/15/2021 6:26:17 AM
First Patient Enrolled in U.S. STAR-T Pivotal Trial Evaluating the DrugSorb-ATR™ Antithrombotic Removal System to Remove Ticagrelor During Cardiothoracic Surgery PR Newswire (US) - 10/14/2021 7:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/13/2021 7:01:40 AM
CytoSorbents Receives Full FDA Investigational Device Exemption (IDE) Approval to Begin U.S. STAR-D Trial on Apixaban and Rivaroxaban Removal by the DrugSorb-ATR™ Antithrombotic Removal System During Urgent Cardiothoracic Surgery PR Newswire (US) - 10/12/2021 4:38:00 PM
CytoSorbents Provides Preliminary Third Quarter Business Update and Revised 2021 Product Revenue Guidance PR Newswire (US) - 10/12/2021 4:35:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/8/2021 7:31:48 AM
CytoSorbents Announces Availability of Preliminary Data Abstracts from Two Endocarditis Studies, including the REMOVE study, to be Presented at the EACTS Conference PR Newswire (US) - 10/7/2021 3:11:00 PM
Merus, Nutriband leads healthcare gainers; Osmotica Pharmaceuticals, Prelude Therapeutics among major losers Seeking Alpha - 10/7/2021 10:59:16 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/14/2021 5:01:28 PM
CytoSorbents to Host International Webinar on the Worldwide Experience Using CytoSorb® in Critically Ill Patients with COVID-19 PR Newswire (US) - 9/14/2021 9:25:00 AM
CytoSorbents Commemorates World Sepsis Day and Sepsis Awareness Month with Key Sepsis-Related Events, Sponsorships and Studies PR Newswire (US) - 9/13/2021 7:08:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/10/2021 4:33:48 PM
CytoSorbents Announces Filing of an Investigational Device Exemption (IDE) for the U.S. Clinical Trial on Apixaban and Rivaroxaban Removal by the DrugSorb-ATR™ Antithrombotic Removal System During Urgent Cardiothoracic Surgery PR Newswire (US) - 9/10/2021 7:08:00 AM
CytoSorbents Announces Webinar Discussing Topline Results from the U.S. CTC Registry using CytoSorb® in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation (ECMO) PR Newswire (US) - 9/8/2021 4:15:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/1/2021 5:28:08 PM
SKLZ, RUN and AMBA among pre market gainers Seeking Alpha - 9/1/2021 8:19:50 AM
Topline Results from CytoSorbents' U.S. CTC Multicenter Registry Demonstrate High Survival using CytoSorb® in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation (ECMO) PR Newswire (US) - 9/1/2021 7:08:00 AM
CytoSorbents and Aferetica Announce the Commercial Launch in Italy of the PerSorb™ Adsorber and PerLife™ Organ Perfusion System, respectively, at the European Society of Organ Transplantation Congress PR Newswire (US) - 8/30/2021 7:08:00 AM
biotech48   Sunday, 01/31/21 11:06:03 AM
Re: Lakersrback post# 25811
Post # of 26888 
you are allowed to post 1 more per day than you should be.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences